Quick Answer
Coherus Oncology, Inc. reported Total Revenue of $0.00 for fiscal year 2018.
Coherus Oncology, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2018 | $0.00 | -100.0% |
| 2017 | $1.56M | -99.2% |
| 2016 | $190.11M | +532.8% |
| 2015 | $30.04M | -3.4% |
| 2014 | $31.11M | +1030.7% |
| 2013 | $2.75M | +44.9% |
| 2012 | $1.90M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2017 | $1.40M | -90.0% | -90.0% |
| June 30, 2016 | $14.07M | +104.9% | +13.8% |
| March 31, 2016 | $12.36M | +112.7% | +80.0% |
| June 30, 2015 | $6.87M | — | +18.2% |
| March 31, 2015 | $5.81M | — | — |
- Coherus Oncology, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2018 period, Coherus Oncology, Inc.’s total revenue has declined by 100.0% (from $1.90 million to $0.00).
- The most recent figure is from Coherus Oncology, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on February 28, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: